Activation of the peripheral endocannabinoid system in human obesity.

By S. Engeli, J. Böhnke, M. Feldpausch, K. Gorzelniak, J. Janke, S. Batkai, P. Pacher, J. Harvey‐White, F. Luft, Arya M. Sharma and 1 more. Diabetes, 2005

711 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology, Physiology

View Paper: https://www.semanticscholar.org/paper/d7f6e16dc5b9537fa78388a4fc7cb6d636bea2df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. N. Delzenne
2. Patrice D Cani

In Pharmacology

1. G. Marsicano
2. P. Pacher
3. S. Batkai
4. George Kunos
5. B. Lutz

In Physiology

1. Patrice D Cani
2. N. Delzenne
3. F. Bäckhed
4. P. Pacher
5. Rob Knight
6. W. D. de Vos

Citations in the corpus

• The emerging role of the endocannabinoid system in endocrine regulation and energy balance. (2006, background): “In such a context, a recent work (60) showed increased circulating levels of AEA and 2-AG in obese women when compared with a lean control group.”
• The endocannabinoid system links gut microbiota to adipogenesis (2010, background): “On the other hand, obesity is also characterised by greater eCB system tone, that is increased eCB plasma levels, altered expression of the cannabinoid receptor 1 (CB 1 mRNA) and increased eCB levels in adipose tissues”
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy (2006, background): “In a study involving 40 women (Engeli et al., 2005), circulating levels of anandamide and 2-AG were significantly increased in 20 obese versus 20 lean subjects, and remained elevated after a 5% diet-induced weight reduction.”
• Neuroendocrine control of food intake. (2008, background): “Circulating levels of endogenous cannabinoids are also increased in obese women compared with lean controls [81].”